Drug information provided by: Merative, Micromedex®
Note: Women of childbearing potential should not use or handle niraparib and abiraterone tablets without protection (eg, gloves).
Niraparib and abiraterone combination is used in combination with prednisone to treat metastatic castration-resistant prostate cancer (prostate cancer that is resistant to medical or surgical treatments that lower testosterone and has spread to other parts of the body) with a deleterious or suspected deleterious BRCA mutation gene. Your doctor will use a test to check for this mutation before you receive the medicine.
This medicine is available only with your doctor's prescription.
This product is available in the following dosage forms:
Portions of this document last updated: May 01, 2024
Copyright: © Merative US L.P. 1973, 2024. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.